MAIA Biotechnology, Inc.
Developing telomere-targeting immuno-oncology therapies for difficult-to-treat cancers.
MAIA | NYSE
Overview
Corporate Details
- ISIN(s):
- US5526411021
- LEI:
- Country:
- United States of America
- Address:
- 444 WEST LAKE STREET, SUITE 1700, 60606 CHICAGO
- Website:
- https://maiabiotech.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
MAIA Biotechnology, Inc. is a clinical-stage immuno-oncology company focused on the development and commercialization of targeted therapies for cancer. The company specializes in creating potential first-in-class drugs with novel mechanisms of action, particularly through its proprietary telomere-targeting platform. MAIA's pipeline aims to address unmet medical needs in oncology by developing treatments intended to improve and extend the lives of patients with difficult-to-treat cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MAIA Biotechnology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MAIA Biotechnology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MAIA Biotechnology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
